GOLDSTEIN JOSEPH L
Insider CIK 1225474 · REGN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2026-01-02 | 2026-01-06 | 1,962 | — | $0 | 1,962 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2026-01-02 | 2026-01-06 | 155 | — | $0 | 6,703 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2025-01-02 | 2025-01-06 | 1,958 | — | $0 | 1,958 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2025-01-02 | 2025-01-06 | 166 | — | $0 | 6,548 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2024-01-23 | 2024-01-25 | 2,707 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-01-23 | 2024-01-25 | 2,707 | $950.00 | $2.57M | 6,382 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2024-01-23 | 2024-01-25 | 2,707 | $625.60 | $1.69M | 9,089 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2024-01-02 | 2024-01-04 | 1,607 | — | $0 | 1,607 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2024-01-02 | 2024-01-04 | 135 | — | $0 | 6,382 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2023-02-06 | 2023-02-08 | 3,613 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2023-02-06 | 2023-02-08 | 3,613 | $800.00 | $2.89M | 6,247 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2023-02-06 | 2023-02-08 | 3,613 | $482.68 | $1.74M | 9,860 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2023-01-03 | 2023-01-05 | 1,929 | — | $0 | 1,929 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2023-01-03 | 2023-01-05 | 165 | — | $0 | 6,247 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2022-03-30 | 2022-04-01 | 2,431 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-03-30 | 2022-04-01 | 2,431 | $700.00 | $1.70M | 6,082 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2022-03-30 | 2022-04-01 | 2,431 | $374.12 | $909.5K | 8,513 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2022-01-03 | 2022-01-05 | 2,707 | — | $0 | 2,707 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2022-01-03 | 2022-01-05 | 191 | — | $0 | 6,082 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2021-09-10 | 2021-09-13 | 2,479 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-09-10 | 2021-09-13 | 2,479 | $650.00 | $1.61M | 5,891 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2021-09-10 | 2021-09-13 | 2,479 | $380.95 | $944.4K | 8,370 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2021-06-07 | 2021-06-08 | 1,930 | — | $0 | 2,431 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-06-07 | 2021-06-08 | 1,930 | $525.00 | $1.01M | 5,891 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2021-06-07 | 2021-06-08 | 1,930 | $374.12 | $722.1K | 7,821 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2021-01-04 | 2021-01-05 | 3,613 | — | $0 | 3,613 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2021-01-04 | 2021-01-05 | 248 | — | $0 | 5,891 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2020-10-05 | 2020-10-06 | 9,212 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2020-10-05 | 2020-10-06 | 9,212 | $520.01 | $4.79M | 14,855 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-10-05 | 2020-10-06 | 9,212 | $600.00 | $5.53M | 5,643 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-09-22 | 2020-09-23 | 20 | $552.36 | $11.0K | 5,643 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2020-09-21 | 2020-09-23 | 4,960 | — | $0 | 2,479 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2020-09-21 | 2020-09-23 | 7,830 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2020-09-21 | 2020-09-23 | 3,784 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-09-21 | 2020-09-23 | 1,356 | $547.28 | $742.1K | 19,061 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-09-21 | 2020-09-23 | 700 | $544.96 | $381.5K | 21,217 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-09-21 | 2020-09-23 | 300 | $543.19 | $163.0K | 21,917 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2020-09-21 | 2020-09-23 | 7,830 | $376.69 | $2.95M | 22,217 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2020-09-21 | 2020-09-23 | 4,960 | $380.95 | $1.89M | 14,387 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-09-21 | 2020-09-23 | 1,530 | $555.74 | $850.3K | 5,663 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-09-21 | 2020-09-23 | 899 | $554.82 | $498.8K | 7,193 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-09-21 | 2020-09-23 | 1,101 | $553.17 | $609.0K | 8,092 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-09-21 | 2020-09-23 | 513 | $552.01 | $283.2K | 9,193 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-09-21 | 2020-09-23 | 1,501 | $551.09 | $827.2K | 9,706 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-09-21 | 2020-09-23 | 1,600 | $550.11 | $880.2K | 11,207 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-09-21 | 2020-09-23 | 2,600 | $549.07 | $1.43M | 12,807 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-09-21 | 2020-09-23 | 3,654 | $548.13 | $2.00M | 15,407 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2020-09-21 | 2020-09-23 | 3,784 | $371.40 | $1.41M | 9,427 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-09-21 | 2020-09-23 | 800 | $546.01 | $436.8K | 20,417 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-08-21 | 2020-08-24 | 1,000 | $617.18 | $617.2K | 5,643 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2020-06-08 | 2020-06-09 | 4,838 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2020-06-08 | 2020-06-09 | 3,000 | — | $0 | 7,838 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2020-06-08 | 2020-06-09 | 3,000 | — | $0 | 4,838 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-06-08 | 2020-06-09 | 771 | $597.51 | $460.7K | 9,364 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-06-08 | 2020-06-09 | 1,111 | $596.47 | $662.7K | 10,135 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-06-08 | 2020-06-09 | 700 | $595.31 | $416.7K | 11,246 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-06-08 | 2020-06-09 | 60 | $592.46 | $35.5K | 11,946 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-06-08 | 2020-06-09 | 100 | $590.47 | $59.0K | 12,006 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-06-08 | 2020-06-09 | 200 | $589.87 | $118.0K | 12,106 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-06-08 | 2020-06-09 | 3,200 | $587.88 | $1.88M | 12,306 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-06-08 | 2020-06-09 | 300 | $587.20 | $176.2K | 15,506 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-06-08 | 2020-06-09 | 200 | $585.58 | $117.1K | 15,806 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-06-08 | 2020-06-09 | 1,175 | $583.67 | $685.8K | 16,006 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-06-08 | 2020-06-09 | 200 | $582.31 | $116.5K | 17,181 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2020-06-08 | 2020-06-09 | 4,838 | $413.33 | $2.00M | 17,481 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2020-06-08 | 2020-06-09 | 3,000 | $413.33 | $1.24M | 12,643 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-06-08 | 2020-06-09 | 200 | $598.07 | $119.6K | 9,164 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-06-08 | 2020-06-09 | 200 | $600.12 | $120.0K | 8,964 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-06-08 | 2020-06-09 | 400 | $601.29 | $240.5K | 8,564 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-06-08 | 2020-06-09 | 1,196 | $602.70 | $720.8K | 7,368 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-06-08 | 2020-06-09 | 525 | $603.82 | $317.0K | 6,843 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-06-08 | 2020-06-09 | 200 | $604.49 | $120.9K | 6,643 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2020-06-08 | 2020-06-09 | 3,000 | $413.33 | $1.24M | 9,643 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-06-08 | 2020-06-09 | 100 | $580.65 | $58.1K | 17,381 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-28 | 2020-06-01 | 1,000 | $578.94 | $578.9K | 6,643 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-06 | 2020-05-06 | 2,000 | $560.00 | $1.12M | 7,643 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2020-03-09 | 2020-03-10 | 2,000 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2020-03-09 | 2020-03-10 | 2,000 | $33.42 | $66.8K | 11,643 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-03-09 | 2020-03-10 | 200 | $468.14 | $93.6K | 11,443 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-03-09 | 2020-03-10 | 100 | $469.80 | $47.0K | 11,343 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-03-09 | 2020-03-10 | 200 | $470.83 | $94.2K | 11,143 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-03-09 | 2020-03-10 | 100 | $471.34 | $47.1K | 11,043 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-03-09 | 2020-03-10 | 73 | $474.88 | $34.7K | 10,970 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-03-09 | 2020-03-10 | 327 | $475.31 | $155.4K | 10,643 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-03-09 | 2020-03-10 | 200 | $476.16 | $95.2K | 10,443 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-03-09 | 2020-03-10 | 500 | $479.21 | $239.6K | 9,943 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-03-09 | 2020-03-10 | 300 | $482.82 | $144.8K | 9,643 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-02-07 | 2020-02-10 | 1,000 | $382.83 | $382.8K | 9,643 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2020-01-02 | 2020-01-06 | 4,361 | — | $0 | 4,361 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2020-01-02 | 2020-01-06 | 320 | — | $0 | 10,643 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2019-11-27 | 2019-12-02 | 1,000 | — | $0 | 2,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2019-11-27 | 2019-12-02 | 1,000 | $33.42 | $33.4K | 11,323 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2019-11-27 | 2019-12-02 | 1,000 | $370.00 | $370.0K | 10,323 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2019-11-22 | 2019-11-22 | 1,000 | — | $0 | 3,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2019-11-22 | 2019-11-22 | 1,000 | $33.42 | $33.4K | 11,323 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2019-11-22 | 2019-11-22 | 1,000 | $360.00 | $360.0K | 10,323 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2019-11-21 | 2019-11-22 | 1,000 | — | $0 | 4,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2019-11-21 | 2019-11-22 | 1,000 | $33.42 | $33.4K | 11,323 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2019-11-21 | 2019-11-22 | 1,000 | $350.00 | $350.0K | 10,323 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2019-11-08 | 2019-11-08 | 1,000 | $340.44 | $340.4K | 10,323 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2019-05-15 | 2019-05-15 | 1,000 | $305.93 | $305.9K | 11,323 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2019-01-10 | 2019-01-11 | 1,791 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2019-01-10 | 2019-01-11 | 1,791 | $273.67 | $490.1K | 14,114 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2019-01-10 | 2019-01-11 | 1,791 | $410.00 | $734.3K | 12,323 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2019-01-02 | 2019-01-04 | 3,784 | — | $0 | 3,784 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award | 2019-01-02 | 2019-01-04 | 323 | — | $0 | 12,323 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2018-09-28 | 2018-10-01 | 709 | — | $0 | 1,791 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2018-09-28 | 2018-10-01 | 709 | $273.67 | $194.0K | 12,709 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2018-09-28 | 2018-10-01 | 709 | $410.00 | $290.7K | 12,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2018-09-27 | 2018-10-01 | 2,000 | — | $0 | 2,500 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2018-09-27 | 2018-10-01 | 2,000 | $400.00 | $800.0K | 12,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2018-09-27 | 2018-10-01 | 2,000 | $273.67 | $547.3K | 14,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2018-09-24 | 2018-09-25 | 1,000 | — | $0 | 4,500 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2018-09-24 | 2018-09-25 | 1,000 | — | $0 | 5,500 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2018-09-24 | 2018-09-25 | 1,000 | $273.67 | $273.7K | 13,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2018-09-24 | 2018-09-25 | 1,000 | $390.00 | $390.0K | 12,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2018-09-24 | 2018-09-25 | 1,000 | $273.67 | $273.7K | 13,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2018-09-24 | 2018-09-25 | 1,000 | $387.29 | $387.3K | 12,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2018-08-02 | 2018-08-03 | 2,000 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2018-08-02 | 2018-08-03 | 2,000 | $380.00 | $760.0K | 12,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2018-08-02 | 2018-08-03 | 2,000 | $57.11 | $114.2K | 14,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2018-07-06 | 2018-07-09 | 2,000 | — | $0 | 2,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2018-07-06 | 2018-07-09 | 2,000 | $57.11 | $114.2K | 14,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2018-07-06 | 2018-07-09 | 2,000 | $370.00 | $740.0K | 12,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2018-07-05 | 2018-07-09 | 2,000 | — | $0 | 4,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2018-07-05 | 2018-07-09 | 2,000 | $57.11 | $114.2K | 14,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2018-07-05 | 2018-07-09 | 2,000 | $360.00 | $720.0K | 12,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2018-03-19 | 2018-03-19 | 2,000 | — | $0 | 6,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2018-03-19 | 2018-03-19 | 2,000 | $350.02 | $700.0K | 12,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2018-03-19 | 2018-03-19 | 2,000 | $57.11 | $114.2K | 14,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2018-03-14 | 2018-03-14 | 2,000 | — | $0 | 8,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2018-03-14 | 2018-03-14 | 2,000 | $340.00 | $680.0K | 12,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2018-03-14 | 2018-03-14 | 2,000 | $57.11 | $114.2K | 14,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2018-02-09 | 2018-02-13 | 1,000 | $325.60 | $325.6K | 12,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2018-01-02 | 2018-01-03 | 7,439 | — | $0 | 7,439 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2017-06-20 | 2017-06-21 | 1,000 | — | $0 | 6,500 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2017-06-20 | 2017-06-21 | 1,000 | $500.01 | $500.0K | 13,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2017-06-20 | 2017-06-21 | 1,000 | $273.67 | $273.7K | 14,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2017-06-09 | 2017-06-13 | 1,000 | — | $0 | 7,500 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2017-06-09 | 2017-06-13 | 1,000 | $482.55 | $482.6K | 13,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2017-06-09 | 2017-06-13 | 1,000 | $273.67 | $273.7K | 14,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2017-01-03 | 2017-01-04 | 7,830 | — | $0 | 7,830 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2016-11-14 | 2016-11-15 | 2,125 | — | $0 | 8,500 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2016-11-14 | 2016-11-15 | 2,125 | $273.67 | $581.5K | 15,125 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2016-11-14 | 2016-11-15 | 2,125 | $450.00 | $956.3K | 13,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2016-07-29 | 2016-08-01 | 2,125 | — | $0 | 10,625 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2016-07-29 | 2016-08-01 | 2,125 | $273.67 | $581.5K | 15,125 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2016-07-29 | 2016-08-01 | 2,125 | $425.00 | $903.1K | 13,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2016-04-06 | 2016-04-07 | 1,000 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2016-04-06 | 2016-04-07 | 1,000 | $425.00 | $425.0K | 13,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2016-04-06 | 2016-04-07 | 1,000 | $425.00 | $425.0K | 13,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2016-04-06 | 2016-04-07 | 1,000 | $177.82 | $177.8K | 14,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2016-04-01 | 2016-04-04 | 2,000 | — | $0 | 1,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2016-04-01 | 2016-04-04 | 2,000 | $400.00 | $800.0K | 14,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2016-04-01 | 2016-04-04 | 2,000 | $177.82 | $355.6K | 16,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2016-03-21 | 2016-03-21 | 2,000 | — | $0 | 3,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2016-03-21 | 2016-03-21 | 2,000 | $375.00 | $750.0K | 14,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2016-03-21 | 2016-03-21 | 2,000 | $177.82 | $355.6K | 16,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2016-01-04 | 2016-01-06 | 9,212 | — | $0 | 9,212 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-08-04 | 2015-08-05 | 2,000 | $586.00 | $1.17M | 14,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-07-15 | 2015-07-15 | 2,000 | $550.00 | $1.10M | 16,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-06-22 | 2015-06-22 | 2,000 | $526.85 | $1.05M | 18,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-05-22 | 2015-05-26 | 2,000 | $513.74 | $1.03M | 22,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-05-22 | 2015-05-26 | 2,000 | $514.81 | $1.03M | 20,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | C Conversion deriv | 2015-05-19 | 2015-05-20 | 20,000 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | C Conversion | 2015-05-19 | 2015-05-20 | 20,000 | — | $0 | 24,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2015-02-20 | 2015-02-20 | 5,000 | — | $0 | 5,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-02-20 | 2015-02-20 | 4,600 | $423.61 | $1.95M | 4,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-02-20 | 2015-02-20 | 400 | $424.14 | $169.7K | 8,600 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2015-02-20 | 2015-02-20 | 5,000 | $177.82 | $889.1K | 9,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2015-01-02 | 2015-01-05 | 10,838 | — | $0 | 10,838 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2014-11-12 | 2014-11-12 | 5,000 | — | $0 | 10,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2014-11-12 | 2014-11-12 | 5,000 | $177.82 | $889.1K | 9,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2014-11-12 | 2014-11-12 | 5,000 | $398.31 | $1.99M | 4,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2014-08-27 | 2014-08-27 | 2,000 | $350.31 | $700.6K | 4,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2014-08-14 | 2014-08-14 | 2,000 | $347.65 | $695.3K | 6,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2014-08-06 | 2014-08-06 | 2,000 | $331.20 | $662.4K | 8,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | C Conversion deriv | 2014-03-25 | 2014-03-27 | 10,000 | — | $0 | 20,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | C Conversion | 2014-03-25 | 2014-03-27 | 10,000 | — | $0 | 10,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2014-02-25 | 2014-02-25 | 1,000 | $338.86 | $338.9K | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2014-02-20 | 2014-02-21 | 50 | $327.17 | $16.4K | 1,950 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2014-02-20 | 2014-02-21 | 100 | $327.14 | $32.7K | 1,850 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2014-02-20 | 2014-02-21 | 850 | $326.96 | $277.9K | 1,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2014-02-12 | 2014-02-13 | 1,000 | $320.62 | $320.6K | 2,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2014-01-02 | 2014-01-03 | 12,750 | — | $0 | 12,750 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-11-06 | 2013-11-06 | 1,000 | $300.74 | $300.7K | 3,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-08-23 | 2013-08-23 | 1,000 | $238.29 | $238.3K | 4,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | C Conversion deriv | 2013-08-14 | 2013-08-15 | 5,000 | — | $0 | 30,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | C Conversion | 2013-08-14 | 2013-08-15 | 5,000 | — | $0 | 5,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-05-28 | 2013-05-28 | 4,000 | $252.20 | $1.01M | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | C Conversion deriv | 2013-05-20 | 2013-05-22 | 4,000 | — | $0 | 35,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | C Conversion | 2013-05-20 | 2013-05-22 | 4,000 | — | $0 | 4,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2013-04-01 | 2013-04-02 | 5,000 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-04-01 | 2013-04-02 | 5,000 | $180.00 | $900.0K | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2013-04-01 | 2013-04-02 | 5,000 | $24.41 | $122.0K | 5,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2013-01-09 | 2013-01-09 | 5,000 | — | $0 | 10,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-01-09 | 2013-01-09 | 5,000 | $185.00 | $925.0K | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2013-01-09 | 2013-01-09 | 5,000 | $57.11 | $285.6K | 5,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2013-01-04 | 2013-01-07 | 2,260 | — | $0 | 7,740 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2013-01-04 | 2013-01-07 | 2,740 | — | $0 | 5,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2013-01-04 | 2013-01-07 | 2,260 | $33.42 | $75.5K | 2,260 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-01-04 | 2013-01-07 | 2,260 | $181.22 | $409.6K | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2013-01-04 | 2013-01-07 | 2,740 | $33.42 | $91.6K | 2,740 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-01-04 | 2013-01-07 | 2,740 | $180.50 | $494.6K | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2013-01-02 | 2013-01-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2012-03-26 | 2012-03-26 | 5,000 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2012-03-26 | 2012-03-26 | 5,000 | $120.00 | $600.0K | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2012-03-26 | 2012-03-26 | 5,000 | $18.61 | $93.0K | 5,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2012-03-15 | 2012-03-21 | 400 | — | $0 | 10,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2012-03-15 | 2012-03-21 | 5,000 | — | $0 | 5,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2012-03-15 | 2012-03-21 | 4,600 | — | $0 | 10,400 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2012-03-15 | 2012-03-21 | 4,600 | $18.61 | $85.6K | 4,600 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2012-03-15 | 2012-03-21 | 4,600 | $110.77 | $509.5K | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2012-03-15 | 2012-03-21 | 400 | $111.06 | $44.4K | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2012-03-15 | 2012-03-21 | 5,000 | $18.61 | $93.0K | 5,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2012-03-15 | 2012-03-21 | 5,000 | $115.00 | $575.0K | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2012-03-15 | 2012-03-21 | 400 | $18.61 | $7.4K | 400 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2012-02-14 | 2012-02-15 | 10,000 | — | $0 | 5,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2012-02-14 | 2012-02-15 | 5,000 | — | $0 | 10,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2012-02-14 | 2012-02-15 | 10,000 | $24.41 | $244.1K | 10,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2012-02-14 | 2012-02-15 | 5,000 | $110.02 | $550.1K | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2012-02-14 | 2012-02-15 | 5,000 | $33.42 | $167.1K | 5,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2012-02-14 | 2012-02-15 | 10,000 | $110.02 | $1.10M | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2012-01-19 | 2012-01-19 | 10,000 | $80.00 | $800.0K | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2012-01-10 | 2012-01-11 | 5,000 | — | $0 | 10,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2012-01-10 | 2012-01-11 | 10,000 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2012-01-10 | 2012-01-11 | 5,000 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2012-01-10 | 2012-01-11 | 10,000 | $19.69 | $196.9K | 20,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2012-01-10 | 2012-01-11 | 5,000 | $74.35 | $371.8K | 10,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2012-01-10 | 2012-01-11 | 10,000 | $75.00 | $750.0K | 10,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2012-01-10 | 2012-01-11 | 5,000 | $74.35 | $371.8K | 10,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2012-01-10 | 2012-01-11 | 5,000 | $23.84 | $119.2K | 15,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2012-01-10 | 2012-01-11 | 5,000 | $19.69 | $98.5K | 15,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2012-01-03 | 2012-01-04 | 15,000 | — | $0 | 15,000 | SEC↗ |